Adding oxaliplatin (OX) to neoadjuvant therapy of locally advanced rectal cancer (LARC): Still a promising option?

e15570Background: Fluoropyrimidine (5-fluorouracil or Capecitabine, FU)-based regimens and radiation are standard-of-care in neoadjuvant treatment of patients with LARC. Meta-analysis (2012) showed...